View in EDS

Efficacy and safety analysis of the use of ibrutinib associated with rituximab for the first-line treatment of patients with chronic lymphocytic leukaemia.

Saved in:
Bibliographic Details
Title: Efficacy and safety analysis of the use of ibrutinib associated with rituximab for the first-line treatment of patients with chronic lymphocytic leukaemia.
Authors: Nascimento AD; Universidade de Brasilia, Distrito Federal, Brazil; Ministério da Saúde, Distrito Federal, Brazil. Electronic address: aline.donascimento@saude.gov.br., Curado DDSP; Universidade de Brasilia, Distrito Federal, Brazil; Ministério da Saúde, Distrito Federal, Brazil., Montezuma T; Universidade de Brasilia, Distrito Federal, Brazil; Hospital Alemão Oswaldo Cruz, São Paulo, Brazil., Barbosa WB; Universidade de Brasilia, Distrito Federal, Brazil; Ministério da Saúde, Distrito Federal, Brazil., Machado-Rugolo J; Universidade de Brasilia, Distrito Federal, Brazil; Hospital das Clínicas da Faculdade de Medicina de Botucatu, Botucatu, Brazil; Universidade de Sorocaba, Sorocaba, Brazil., Fachi MM; Universidade de Brasilia, Distrito Federal, Brazil; Hospital Alemão Oswaldo Cruz, São Paulo, Brazil.
Source: Hematology, transfusion and cell therapy [Hematol Transfus Cell Ther] 2026 Jan-Mar; Vol. 48 (1), pp. 106234. Date of Electronic Publication: 2025 Dec 15.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Editora Ltda Country of Publication: Brazil NLM ID: 101725732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2531-1387 (Electronic) Linking ISSN: 25311379 NLM ISO Abbreviation: Hematol Transfus Cell Ther Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41401713
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Efficacy and safety analysis of the use of ibrutinib associated with rituximab for the first-line treatment of patients with chronic lymphocytic leukaemia.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Nascimento+AD%22">Nascimento AD</searchLink>; Universidade de Brasilia, Distrito Federal, Brazil; Ministério da Saúde, Distrito Federal, Brazil. Electronic address: aline.donascimento@saude.gov.br.<br /><searchLink fieldCode="AU" term="%22Curado+DDSP%22">Curado DDSP</searchLink>; Universidade de Brasilia, Distrito Federal, Brazil; Ministério da Saúde, Distrito Federal, Brazil.<br /><searchLink fieldCode="AU" term="%22Montezuma+T%22">Montezuma T</searchLink>; Universidade de Brasilia, Distrito Federal, Brazil; Hospital Alemão Oswaldo Cruz, São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Barbosa+WB%22">Barbosa WB</searchLink>; Universidade de Brasilia, Distrito Federal, Brazil; Ministério da Saúde, Distrito Federal, Brazil.<br /><searchLink fieldCode="AU" term="%22Machado-Rugolo+J%22">Machado-Rugolo J</searchLink>; Universidade de Brasilia, Distrito Federal, Brazil; Hospital das Clínicas da Faculdade de Medicina de Botucatu, Botucatu, Brazil; Universidade de Sorocaba, Sorocaba, Brazil.<br /><searchLink fieldCode="AU" term="%22Fachi+MM%22">Fachi MM</searchLink>; Universidade de Brasilia, Distrito Federal, Brazil; Hospital Alemão Oswaldo Cruz, São Paulo, Brazil.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101725732%22">Hematology, transfusion and cell therapy</searchLink> [Hematol Transfus Cell Ther] 2026 Jan-Mar; Vol. 48 (1), pp. 106234. <i>Date of Electronic Publication: </i>2025 Dec 15.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Editora+Ltda%22">Elsevier Editora Ltda </searchLink><i>Country of Publication: </i>Brazil <i>NLM ID: </i>101725732 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2531-1387 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225311379%22">25311379 </searchLink><i>NLM ISO Abbreviation: </i>Hematol Transfus Cell Ther <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41401713
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.htct.2025.106234
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 106234
    Titles:
      – TitleFull: Efficacy and safety analysis of the use of ibrutinib associated with rituximab for the first-line treatment of patients with chronic lymphocytic leukaemia.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Nascimento AD
      – PersonEntity:
          Name:
            NameFull: Curado DDSP
      – PersonEntity:
          Name:
            NameFull: Montezuma T
      – PersonEntity:
          Name:
            NameFull: Barbosa WB
      – PersonEntity:
          Name:
            NameFull: Machado-Rugolo J
      – PersonEntity:
          Name:
            NameFull: Fachi MM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2026 Jan-Mar
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2531-1387
          Numbering:
            – Type: volume
              Value: 48
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Hematology, transfusion and cell therapy
              Type: main
ResultId 1